Research
The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
BMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b2376 (Published 30 June 2009) Cite this as: BMJ 2009;338:b2376
Related articles
- Paper Published: 13 September 1997; BMJ 315 doi:10.1136/bmj.315.7109.629
- Editorial Published: 01 September 2010; BMJ 341 doi:10.1136/bmj.c4681
- Paper Published: 26 June 2003; BMJ 326 doi:10.1136/bmj.326.7404.1423
- Analysis Published: 28 July 2010; BMJ 341 doi:10.1136/bmj.c3531
- Research Published: 20 March 2008; BMJ 336 doi:10.1136/bmj.39472.580984.AE
- Research Published: 30 March 2011; BMJ 342 doi:10.1136/bmj.d1672
- Research Published: 20 May 2010; BMJ 340 doi:10.1136/bmj.c2197
- Research Published: 29 May 2014; BMJ 348 doi:10.1136/bmj.g3244
- Research Methods & Reporting Published: 08 September 2014; BMJ 349 doi:10.1136/bmj.g5293
- Letter Published: 30 July 2014; BMJ 349 doi:10.1136/bmj.g4876
- Research Published: 28 June 2016; BMJ 353 doi:10.1136/bmj.i3283
- Education And Debate Published: 04 September 2003; BMJ 327 doi:10.1136/bmj.327.7414.557
- Primary Care Published: 07 April 2005; BMJ 330 doi:10.1136/bmj.38398.408032.8F
- PRIMARY CARE Published: 24 March 2005; BMJ doi:10.1136/bmj.38398.408032.8F
See more
- Semaglutide’s CVD indication could cost US Medicare $145bn extra a yearBMJ August 28, 2024, 386 q1878; DOI: https://doi.org/10.1136/bmj.q1878
- Semaglutide: UK regulator approves drug for prevention of cardiovascular eventsBMJ July 25, 2024, 386 q1660; DOI: https://doi.org/10.1136/bmj.q1660
- Why India is failing to track heatstroke fatalities properlyBMJ July 17, 2024, 386 q1437; DOI: https://doi.org/10.1136/bmj.q1437
- Mail on Sunday articles that accused three commentators of being “statin deniers” were misinformed, judge rulesBMJ June 26, 2024, 385 q1424; DOI: https://doi.org/10.1136/bmj.q1424
- Sixty seconds on . . . flyingBMJ June 10, 2024, 385 q1266; DOI: https://doi.org/10.1136/bmj.q1266
Cited by...
- Age and sex specific thresholds for risk stratification of cardiovascular disease and clinical decision making: prospective open cohort study
- Health Economics Assessment of Statin Therapy Initiation Thresholds for Atherosclerosis Prevention in China: a Cost-Effectiveness Analysis
- Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial)
- Cost-effectiveness of Ezetimibe plus statin lipid-lowering therapy: A systematic review and meta-analysis of cost-utility studies
- Clinical impact of 2020 American Heart Association statement on menopause and cardiovascular disease risk
- Is targeted lung cancer screening an opportune time to address cardiovascular risk?
- Hyperlipidaemia in primary biliary cholangitis: treatment, safety and efficacy
- General Practitioners adherence to prescribing guidelines for statins in the United Kingdoms
- Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews
- Obstacles aux interventions cliniques liees a lactivite physique dans le traitement des maladies cardiometaboliques
- Impediments to clinical application of exercise interventions in the treatment of cardiometabolic disease
- Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999-2014)
- Statin-prescribing trends for primary and secondary prevention of cardiovascular disease
- Competing demands and opportunities in primary care
- CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects
- Implications of Coronary Artery Calcium Testing for Treatment Decisions Among Statin Candidates According to the ACC/AHA Cholesterol Management Guidelines: A Cost-Effectiveness Analysis
- Utility of 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines in HIV-Infected Adults With Carotid Atherosclerosis
- Cost-effectiveness of the polypill versus risk assessment for prevention of cardiovascular disease
- Statin Use and the Risk of Cataracts: A Systematic Review and Meta-Analysis
- CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines
- Statin Therapy as Primary Prevention in Exercising Adults: Best Evidence for Avoiding Myalgia
- Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study
- Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data
- Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects
- Systemic inflammation in patients with inflammatory joint diseases does not influence statin dose needed to obtain LDL cholesterol goal in cardiovascular prevention
- Use of statins is associated with lower serum total and non-sex hormone-binding globulin-bound testosterone levels in male participants of the Rotterdam Study
- Statin use in adults at high risk of cardiovascular disease mortality: cross-sectional analysis of baseline data from The Irish Longitudinal Study on Ageing (TILDA)
- Dietary saturated fat intake and atherosclerotic vascular disease mortality in elderly women: a prospective cohort study
- Initiation rates of statin therapy for the primary prevention of cardiovascular disease: an assessment of differences between countries of the UK and between regions within England
- Is Statin Exposure Associated with Occurrence or Better Outcome in Giant Cell Arteritis? Results from a French Population-based Study
- Regression discontinuity designs: an approach to the evaluation of treatment efficacy in primary care using observational data
- Evidence-Based Prescribing: Combining Network Meta-Analysis With Multicriteria Decision Analysis to Choose Among Multiple Drugs
- Unanswered questions about higher potency statins and the risk of new diabetes
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
- Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases
- Nonfatal Outcomes in the Primary Prevention of Atherosclerotic Cardiovascular Disease: Is All-Cause Mortality Really All That Matters?
- Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein
- Perspective on the 2013 American Heart Association/American College of Cardiology Guideline for the Use of Statins in Primary Prevention of Low-Risk Individuals
- Effect of cardiovascular prevention strategies on incident coronary disease hospitalisation rates in Spain; an ecological time series analysis
- Effect of Collaborative Care for Depression on Risk of Cardiovascular Events: Data From the IMPACT Randomized Controlled Trial
- Benefits of Statins in Elderly Subjects Without Established Cardiovascular Disease: A Meta-Analysis
- The Role of Statins in Diabetes Treatment
- Comparative Tolerability and Harms of Individual Statins: A Study-Level Network Meta-Analysis of 246 955 Participants From 135 Randomized, Controlled Trials
- Vascular function and atherosclerosis progression after 1 y of flavonoid intake in statin-treated postmenopausal women with type 2 diabetes: a double-blind randomized controlled trial
- Statin use and clinical outcomes in older men: a prospective population-based study
- A Hospital System's Wellness Program Linked To Health Plan Enrollment Cut Hospitalizations But Not Overall Costs
- Assessing Appropriateness of Lipid Management Among Patients With Diabetes Mellitus: Moving From Target to Treatment
- Patients' Expectations of Screening and Preventive Treatments
- "The Child Is Father of the Man" (William Wordsworth, 1802)
- The Controversies of Statin Therapy: Weighing the Evidence
- ASPIRE-2-PREVENT: a survey of lifestyle, risk factor management and cardioprotective medication in patients with coronary heart disease and people at high risk of developing cardiovascular disease in the UK
- Inpatient statin use predicts improved ischemic stroke discharge disposition
- Controversy and Consensus About Statin Use: It Is Not About the Sex
- The efficacy and cost-effectiveness of statins in low-risk patients
- Comparative Effectiveness and Cost-Effectiveness of Computed Tomography Screening for Coronary Artery Calcium in Asymptomatic Individuals
- Effects of statin medication on mortality risk associated with type 2 diabetes in older persons: the population-based AGES-Reykjavik Study
- Do statins improve outcomes and delay the progression of non-rheumatic calcific aortic stenosis?
- Practical use of the Framingham risk score in primary prevention: Canadian perspective
- Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis
- Statins for primary prevention of cardiovascular disease
- Association of Combinations of Lipid Parameters With Carotid Intima-Media Thickness and Coronary Artery Calcium in the MESA (Multi-Ethnic Study of Atherosclerosis)
- BMJ extends its European reach
- Shifting views on lipid lowering therapy
- Individualising the risks of statins in men and women in England and Wales: population-based cohort study
- Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database
- Statins for Primary Prevention: Homing in on Effectiveness
- Let's start with reporting
- Statins for Primary Prevention of Cardiovascular Disease